130 related articles for article (PubMed ID: 21743116)
21. Complementary stimulation of hepatobiliary transport and detoxification by rifampicin and ursodeoxycholic acid in humans.
Duttala S; Tobi M; Dingell JD
Gastroenterology; 2006 Feb; 130(2):619-20; author reply 620. PubMed ID: 16472623
[No Abstract] [Full Text] [Related]
22. [Anicteric form of progressive familial intrahepatic cholestasis (Byler syndrome)].
Masmoudi A; Hadj-Taieb I; Kammon T; Mseddi M; Boudaya S; Chaabouni M; Hachicha M; Turki H
Ann Dermatol Venereol; 2008 Mar; 135(3):228-30. PubMed ID: 18374858
[No Abstract] [Full Text] [Related]
23. Ursodeoxycholic acid for intrahepatic cholestasis of pregnancy: good for the mother, not bad for the baby.
Carey EJ; White P
Evid Based Med; 2013 Dec; 18(6):e55. PubMed ID: 23635844
[No Abstract] [Full Text] [Related]
24. [Intrahepatic cholestasis of pregnancy].
Pevtichev S; Dimitrova V
Akush Ginekol (Sofiia); 2013; 52(1):35-41. PubMed ID: 23805459
[TBL] [Abstract][Full Text] [Related]
25. Effect of ursodeoxycholic acid on chronic intrahepatic cholestasis due to sarcoidosis.
Bécheur H; Dall'osto H; Chatellier G; Charton-Bain MC; Aubertin JM; Attar A; Bloch F; Petite JP
Dig Dis Sci; 1997 Apr; 42(4):789-91. PubMed ID: 9125650
[No Abstract] [Full Text] [Related]
26. [Recent progress in the diagnosis and therapy of autoimmune hepatitis].
Zenia M; Toda G
Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1763-7. PubMed ID: 10581761
[No Abstract] [Full Text] [Related]
27. URSO in obstetric cholestasis: not a bear market.
Elias E
Gut; 1999 Sep; 45(3):331-2. PubMed ID: 10446097
[No Abstract] [Full Text] [Related]
28. [Treatment of autoimmune hepatic diseases].
Bueverov AO
Klin Med (Mosk); 2004; 82(10):62-6. PubMed ID: 15584604
[TBL] [Abstract][Full Text] [Related]
29. Acute seronegative autoimmune hepatitis.
Ozaslan E; Samsar U; Erden E
Hepatogastroenterology; 2010; 57(98):334-5. PubMed ID: 20583438
[TBL] [Abstract][Full Text] [Related]
30. [Intrahepatic cholestasis in pregnancy. What to consider in jaundice and pruritus].
Kenngott S; Lohse P; Beuers U
MMW Fortschr Med; 2002 Dec; 144(50):41-4. PubMed ID: 14610864
[TBL] [Abstract][Full Text] [Related]
31. Intrahepatic Cholestasis Owing to a Novel Heterozygous ABCG8 Mutation and SLC4A2 Polymorphism With Favorable Outcome Under Ursodeoxycholic Acid.
Ciocan D; Voican CS; Barbu V; Corpechot C; Rainteau D; Prevot S; Lebrun A; Perlemuter G
Am J Gastroenterol; 2019 Sep; 114(9):1556-1559. PubMed ID: 31335361
[No Abstract] [Full Text] [Related]
32. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
[TBL] [Abstract][Full Text] [Related]
33. Ursodeoxycholic acid (UDCA) for the treatment of amoxycillin-clavulanate potassium (Augmentin)-induced intra-hepatic cholestasis: report of two cases.
Katsinelos P; Vasiliadis T; Xiarchos P; Patakiouta F; Christodoulou K; Pilpilidis I; Eugenidis N
Eur J Gastroenterol Hepatol; 2000 Mar; 12(3):365-8. PubMed ID: 10750660
[TBL] [Abstract][Full Text] [Related]
34. [Intrahepatic cholestasis in pregnancy treated with ursodeoxycholic acid].
Grønlund LA
Ugeskr Laeger; 1999 Sep; 161(39):5433-4. PubMed ID: 10553357
[TBL] [Abstract][Full Text] [Related]
35. Application of ursodeoxycholic acid (UDCA) in the therapy of liver and biliary duct diseases in children.
Lebensztejn DM
Med Sci Monit; 2000; 6(3):632-6. PubMed ID: 11208384
[TBL] [Abstract][Full Text] [Related]
36. [Ursodeoxycholic acid treatment shortens the course of cholestasis in two patients with benign recurrent intrahepatic cholestasis].
Nicolás I; Pons JA; Vargas A; Gallardo F; Albaladejo A; Nicolás JM
Gastroenterol Hepatol; 2003; 26(7):421-3. PubMed ID: 12887856
[TBL] [Abstract][Full Text] [Related]
37. [Intrahepatic cholestasis of pregnancy].
Lengyel G; Fehér J
Orv Hetil; 2004 Oct; 145(41):2103-5. PubMed ID: 15586585
[TBL] [Abstract][Full Text] [Related]
38. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis.
Jacquemin E; Hermans D; Myara A; Habes D; Debray D; Hadchouel M; Sokal EM; Bernard O
Hepatology; 1997 Mar; 25(3):519-23. PubMed ID: 9049190
[TBL] [Abstract][Full Text] [Related]
39. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism.
Crosignani A; Podda M; Bertolini E; Battezzati PM; Zuin M; Setchell KD
Hepatology; 1991 Jun; 13(6):1076-83. PubMed ID: 2050325
[TBL] [Abstract][Full Text] [Related]
40. Deep cholestatic jaundice as the predominant manifestation in autoimmune hepatitis.
Wang SB; Wang JH; Zheng RH; Zhong BH; Chen MH
Hepatogastroenterology; 2010; 57(98):326-9. PubMed ID: 20583436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
